PS www.ProStocks.com
|
|
Dr. Lal Path Labs Limited Our Company was incorporated as 'Dr. Lal PathLabs Private Limited', a private limited cornpary under the Cornpanies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana ('RoC') on February 14,1995 at Delhi. Subsequently, the name of our Company was changed to 'Dr. Lal PathLabs Limited' upon conversion of our Company into a public limited company pursuant to a special resolution of the shareholders of our Company dated August 7, 2015 and a fresh certificate of incorpotation was issued by the RoC on August 19,2015. There has been no change in the registered office of our Company since inoorporalion of our Company. Registered Office: Eskay House54, Hanurnan Road, New
Delhi 110 001, India: Telephone: +91 11 3040 3210; Facsimile: +91
11 3040 3204 PROMOTERS OF OUR COMPANY: (HONY.) BRIG. DR. ARVIND LAL, DR. VANDANA LAL AND ESKAY HOUSE (HUF) The Equity Shares are proposed to be listed on the BSE Limited ('BSE') and the National Stock Exchange of India Limited ('NSE') and the trading will commence on or about December 23,2015. INITIAL PUBLIC OFFERING OF 11,600,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH ('EQUITY SHARES') OF DR. LAL PATHLABS LIMITE D (OUR 'COMPANY' OR THE 'ISSUER') FOR CASH AT A PRICE OF RS 550 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF RS 540 PER EQUITY SHARE (THE 'OFFER PRICE'), AGGREGATING RS 6,319.10 MILLION (THE 'OFFER') THROUGH AN OFFER FOR SALE OF 1,251,996 EQUITY SHARES AGGREGATING RS 687.47 MILLION BY (HONY,) BRIG, DR. ARVIND LAL, 2,056747 EQUITY SHARES AGGREGATING RS 1,120.41 MILLION BY DR. VANDANA LAL, 238.226 EQUITY SHARES AGGREGATING RS 129.77 MILLION BY ESKAY HOUSE (HUF), 550,386 EQUITY SHARES AGGREGATING RS 299.82 MILLION BY MR ANJANEYA LAL (COLLECTIVELY, THE 'PROMOTER SELLING SHAREHOLDERS' AND SUCH EQUITY SHARES BEING THE 'PROMOTER OFFERED SHARES''), 5,860,000 EQUITY SHARES AGGREGATING RS 3,192.24 MILLION BY WAGNER LIMITED 1,471,575 EQUITY SHARES AGGREGATING RS 801.64 MILLION BY WESTB RIDGE CROSSOVER FUND, LLC, 161,070 EQUITY SHARES AGGREGATING RS 87.74 MILLION BY SANJEEVINI INVESTMENT HOLDINGS (COLLECTIVELY. THE ''INVESTOR SELLING SHAREHOLDERS' AND SUCH EQUITY SHARES BEING THE 'INVESTOR OFFERED SHARES', AND WITH THE PROMOTER SELLING SHAREHOLDERS, THE 'SELLING SHAREHOLDERS') (THE 'OFFER FOR SALE'). THE OFFER SHALL CONSTITUTE 14.04% OF THE POST OFFER PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY. OUR COMPANY AND THE SELLING SHAREHOLDERS, IN CONSULTATION WITH THE BOOK RUNNING LEAD MANAGERS, OFFERED A DISCOUNT OF RS 15 ON THE OFFER PRICE TO RETAIL INDIVIDUAL BIDDERS ('RETAIL DISCOUNT'). OFFER PRICE: BID/OFFER OPENED ON DECEMBER 08,2015* *The Anchor Investor Bid/Offer Period was one Working Day prior to the Bid/Offer Opening Date i.e. December 7, 2015 in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 ('SEBI Regulations'). Pursuant to Rule l9(2)(b) of the Securities Contracts Regulation Rules, 1957, as
amended ('SCRR') read with Regulation 41 of the SEBl Regulations, the Offer is
being made for at least 10% of the post-Offer paid-up Equity Share capital of our Company.
The offer is being made through the Book Building Process in accordance with Regulation
26{1) of the SEBI Regulations, wherein 50% of the Offer was made available for allocation
on a proportionate basis to Qualified institutional Buyers ('QIB Portion'). Our
Company, the Promoter Selling Shareholders and the Investor Selling Shareholders allocated
60% of the QIB Portion to Anchor Investors at the Anchor Investor Allocation Price, on a
discretionary basis, out of which al least one-third was reserved for allocation to
domestic Mulual Funds at or above the Anchor Investor Allocation. Such number of Equity
Shares representing 5% of the Net QlB Portion (other than Anchor Investor Portion) was
made available for allocation on a proportonate basis to Mutua Funds only.Tha remainder of
the Net QlB Portion was mada available for allocation on a proportionate basis to QIBs
(other than Anchor Investors), including Mutual Funds, subject to valid Bids being
received from them at or above the Offer Price. Further, not lass than 15% of the Offer
was made available for allocation on a proportionate basis, to Non institutional Bidders
and not less than 35% of the Offer was made available for allocation to Retail Individual
Bidders In accordance with the SEBI Regulations, subject to valid bids being received from
them at or above the Offer Price such that, subject to availability of Equity Shares each
Retail individual bidders shall be Allotted not less- than the minimum Bid Lot.and the
remaining Equity Shares, if available, could be allotted to all Retail Individual Bidders
on a proportionate basis, All investors, other than Anchor Investors, were permitted to
participate through the Applications Supported by Blocked Amount ('ASBA')
process by providing the details of the respective bank accounts which the corresponding
Bid Amount will be blocked by the SCSBs. However, QlBs (excluding Anchor investors) and
Non-Institutional Bidders were mandatorily required to submit their Bids by way of ASBA
only. Anchor Investors were not permitted to participate in the Offer through the ASBA
process. For details, see 'Offer Procedure' on page 409 of the Prospectus.
Final Demand
The Basis of Allolmentwas finakjed in consultation with the Designated Stock Exchange, being NSE on December 19,201S. A. Allotment to Retail Individual Bidders (After Technical Rejections) (including ASBA Applications) The Basis of Allotment to the Retail Individual Bidders, who have bid at cut-otf or at the Offer Price of Rs.550 per Equity Share, was Finalized in consultation with the NSE. This category has been subscribed to the extent of 4.0972 times. The total number of Equity Shares Allotted in Retail Individual Bidders category is 4,060,000 Equity Shanes to 203,000 successful applicants. Since the number of Retail Individual Investors who had submitted valid Bids in the Offer was more than Maximum Retail Individual Investors Allottees, the Retail Individual Investors (in that category) who were allotted minimum Bid Lot have been determined on the basis of draw of lots. The category-wise details of the Basis of Allotment are as under:
B. Allotment to Non-lnstitulional Bidders (After Technical Rejections) The Basis of Allolment 10 the Non-Institutional Bidders, who have bid at the Offer Price of Rs.550 per Equiiy Share or above, was. finalized in consultation with the NSE. This category has been subscribed to the extent of 61.2080 times. The total number of Equity Shares Allotted in this category is 1,740,000 Equity Shares to 291 successlul applicants. Since the proportionate allotment for Non-Institutional investors was less than the minimum Bid Lot per Bidder,the successful Bidders In the Non-Institutional investors category were determined by draw of lots. The category-wise details of the Basis of Allotment are as under (Sample):
C. Allotment to QIBs (excluding Anchor Investors) Allotment QIBs, who have Bid al the Offer Price of Rs.550 per Equity Share or above, has been done on a proportionale basis in consultation with the NSE. This category has bean subscribed to the extent of 72.4125 times of Net QlB portion. As par the SEBI Regulations. Mutual Funds were Allotted 116,000 of the Equity Shares of Net QIB portion available i.e. 116,000 Equity Shares and other QIBs and unsatisfied demand of Mutual Funds were Allotted the remaining available Equity Shares i.e 2,204,000 Equiiy Shares on a proportionate basis. The total number of Equiiy Shares Allotted in the QlB category is 2,320,000 Equiiy Shares, which ware allotted to 146 successful Applicant. The category-wise details of the Basis of Allolment are as under:
D. Allotment to Anchor Investors The Company and the Selling Shareholders have allotted 3,480,000 Equity Shares to 26 Anchor Investors, in consultation with the BRLM5. In accordance with the SEBI Regulations, this represents 30% of the QlB Portion.
The IPO Committee of our Company at its meeting held on December 20,2015, has taken on record the basis,of allotment of Equity Shares approved by the Designated Stock Exchange, being NSE and has allotted the Equity Shares to various successful applicants. The CAN-cum-Refund Orders and Allotment Advice have been dispatched to the address of the investors as registered with the depositories on or before December 22, 2015. Further, instructions to the SCSBs have been dispatched/mailed on December 19, 2015. In case the same is not received within ten days, investors may contact the Registrar to the Offer at the address given below. The Refund Orders have been over-printed with the bank account details as registered, if any, with the depositories. The Equity Shares allotted to the successful allottees have been uploaded on December 21,2015 forr credit into the respective beneficiary accounts subject to validation of the account deteils with the depositories concerned. Our Company is taking steps to get the Equity Shares admitted for trading on the NSE and BSE within 12 working days of the closure of the Offer, The Company has filed the listing application with BSE end NSE on December 21,2015. INVESTORS PLEASE NOTE The deteils of the allotment made will be hosted on the website of the Registrar to the Offer, Link Intime India Private Limited at www.1inkmtime.co.in. All future correspondence in this regard may kindly be addressed to the Registrar to the Offer quoting full name of the First/ Sole applicant. Serial number of the Bid-Cum-Application form, number of Equity Shares bid for, name of the Member of the Syndicate, place where the bid was submitted and payment details at the address given below: Link Intime India Private Limited C-13.Pannalal Silk Mills Compound, L.B.S. Marg Bhandup(West), Mumbai400 078.
Maharashha, India THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF DR. LAL PATHLABS LIMITED
|
The Dr Lal PathLabs IPO basis of allotment (published above) tells you how shares are allocated to you in Dr Lal PathLabs IPO and category wise demand of IPO share.
Visit the Dr Lal PathLabs IPO allotment status page to check the number of shares allocated to your application.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
DRHP
